Kevin McGovern is the Chairman and CEO of McGovern Capital, a single-family office. Through McGovern Capital and its affiliates, he has co-founded over twenty-five (25) companies, six of which have become world/category leaders, and he has been lead negotiator/principal in over fifteen (15) global joint ventures.
McGovern Capital serves as an investment, strategy and licensing participant and advisor to global businesses. McGovern regularly speaks at business, academic and family office conferences in the US, Europe, Middle East, and Asia. McGovern was a founder of SoBe Beverages, the fastest growing beverage company ever in the US (sold to Pepsi), and
McGovern Capital is also currently involved in several consumer technologies including several innovative food and beverage companies; unique skincare technologies for women of color and CBD; interests in several teams/organizations in e-Sports. It is a principal in a leading drug company obtaining the first FDA approved drug for plaque removal in the human body; and also participates in various impact/environmental opportunities such as clean/filtered water, plasticsto-fuel. and carbon underground agricultural products.
McGovern is actively involved in the medical cannabis industry with numerous companies across the globe. He is Chairman of Israel Plant Sciences which has numerous subsidiaries working on uniform seed breeding for all agricultural purposes and cutting edge drug solutions for intestinal bowel disease (IBD), addiction, and colon cancer. McGovern Capital is an investor in many US, Canadian and other global entities in the cannabis industry and currently in the US serves as Vice Chairman of PTS, a multi-state operator which has various state licenses/dispensaries including Illinois, Michigan, and Massachusetts. McGovern speaks at leading US and global cannabis conferences and events on topics ranging from medical marijuana and market trends to due diligence strategies for getting into the industry.